What is PharmaLabs?
PharmaLabs operates as a premier provider of sterile injectable preparations and advanced needle-free gels, specifically targeting the treatment of erectile dysfunction. By maintaining a nationwide network of healthcare providers, the company serves as a critical link in the medical supply chain, offering non-commercially available products that meet rigorous safety standards. The organization distinguishes itself through the use of FDA-approved ingredients and mandatory independent third-party laboratory testing for every batch produced. Their state-of-the-art facility, featuring clean rooms that exceed United States Pharmacopeia guidelines, reflects a commitment to high-quality pharmaceutical compounding and patient safety, supported by a specialized team of pharmacists and technicians.
How much funding has PharmaLabs raised?
PharmaLabs has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in PharmaLabs
PPP
Public-Private Partnership
What's next for PharmaLabs?
With this late-stage financing, PharmaLabs is well-positioned to scale its production capacity and expand its reach within the specialized healthcare market. The strategic allocation of these funds will likely focus on enhancing facility infrastructure, optimizing supply chain logistics, and potentially broadening the company's therapeutic portfolio. As the demand for high-quality, compounded pharmaceutical solutions continues to rise, PharmaLabs is poised to leverage its technical expertise to capture additional market share, ensuring that its specialized treatments remain accessible to the growing network of physicians and patients who rely on their precision-engineered medical products.
See full PharmaLabs company page
